NU SKIN ENTERPRISES Q2 2026 Earnings Preview: Recent $NUS Insider Trading, Hedge Fund Activity, and More
Nu Skin Enterprises (NUS) is set to report Q2 2026 earnings on Aug. 10 after market close, according to Finnhub. Analysts expect revenue of $348.652M and EPS of $0.20. The article cites Q1 2026 revenue of $320.6M, down 12.04% YoY, plus recent insider sales and institutional 13F changes.
How this was made

The 30-second read
Why it matters
For NUS, the main tradable element is the scheduled Aug 10 after-hours earnings event and the consensus revenue and EPS figures cited. The insider and hedge-fund activity are secondary context, not a new fundamental catalyst.
Market read
Traders can use the consensus revenue ($348.652M) and EPS ($0.20) and the Aug 10 after-hours timing to plan earnings-risk exposure for NUS.
What to watch
The article does not discuss guidance, margins, or segment trends, so traders should focus on what management reports on Aug 10 rather than the positioning data alone.
Background
The piece frames NU Skin Enterprises’ upcoming Q2 2026 earnings release and summarizes recent insider sales and institutional holdings changes.
Ticker impact
NU Skin Enterprises is scheduled to report Q2 2026 earnings Aug 10 after the close, with consensus revenue of $348.652M and EPS of $0.20.
Near-term volatility is likely around the Aug 10 after-hours earnings release versus the $348.652M revenue and $0.20 EPS expectations.
The article provides the earnings timing and consensus numbers, but it does not include a new company-specific fundamental update beyond insider sales and institutional position changes.
Market effects
Limited sector read-through because the article is primarily a single-name earnings preview plus trading-flow data.
No clear regional spillover described.
No global macro or cross-border catalyst mentioned.
Counterpoint
Insider sales and mixed 13F flows may be routine and not predictive of the earnings outcome; the only actionable driver here is the earnings print versus consensus.
Key entities
- companyNU Skin Enterprises
Subject of the earnings preview, scheduled to report Q2 2026 results on Aug 10 after market close.
- insiderEdwina D Woodbury
Named insider who sold 7,203 shares of NUS in the past 6 months per the article.
- insiderJames M Winett
Named insider who sold 7,203 shares of NUS in the past 6 months per the article.